Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Ramon Colomer

1-50 of 85 results

View this query on the Wikidata Query Service
Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation.

scientific article
Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells

scientific article
Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells

scientific article published on February 2008
Prospective transGEICAM study of the impact of the 21-gene Recurrence Score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancer.

scientific article
CCR5 expression influences the progression of human breast cancer in a p53-dependent manner

scientific article
Characterization of a growth factor that binds exclusively to the erbB-2 receptor and induces cellular responses

scientific article published on March 15, 1992
Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer: The NEfERT-T Randomized Clinical Trial

scientific article published on 14 April 2016
Fatty acid metabolism in breast cancer cells: differential inhibitory effects of epigallocatechin gallate (EGCG) and C75.

scientific article published on 28 September 2007
Risk factors for treatment-related death in elderly patients with aggressive non-Hodgkin's lymphoma: results of a multivariate analysis

scientific article published on 01 June 1998
Novel Inhibitors of Fatty Acid Synthase with Anticancer Activity

scientific article published on 01 December 2009
BRCA1 and acetyl-CoA carboxylase: the metabolic syndrome of breast cancer

scientific article
A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines.

scientific article published on 16 December 2011
Why does tumor-associated fatty acid synthase (oncogenic antigen-519) ignore dietary fatty acids?

scientific article published in January 2005
Patient selection in high-dose chemotherapy trials: relevance in high-risk breast cancer

scientific article published on October 1, 1997
Protein array technology to detect HER2 (erbB-2)-induced 'cytokine signature' in breast cancer.

scientific article published on 26 March 2007
New synthetic inhibitors of fatty acid synthase with anticancer activity

scientific article published on 16 May 2012
Phase II study of trastuzumab and cisplatin as first-line therapy in patients with HER2-positive advanced gastric or gastroesophageal junction cancer

scientific article published on 01 March 2011
Low levels of basic fibroblast growth factor (bFGF) are associated with a poor prognosis in human breast carcinoma

scientific article published on January 1, 1997
Low-scale phosphoproteome analyses identify the mTOR effector p70 S6 kinase 1 as a specific biomarker of the dual-HER1/HER2 tyrosine kinase inhibitor lapatinib (Tykerb) in human breast carcinoma cells.

scientific article published on 17 February 2008
Biweekly paclitaxel plus gemcitabine in advanced breast cancer: phase II trial and predictive value of HER2 extracellular domain.

scientific article published in February 2004
EGF prevents the neuroendocrine differentiation of LNCaP cells induced by serum deprivation: the modulator role of PI3K/Akt

scientific article
Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells.

scientific article published on 3 November 2014
Strategies to design clinical studies to identify predictive biomarkers in cancer research.

scientific article published on 30 December 2016
Phase I clinical trial of nintedanib plus paclitaxel in early HER-2-negative breast cancer (CNIO-BR-01-2010/GEICAM-2010-10 study).

scientific article published on 24 July 2014
Immune-related adverse events predict the therapeutic efficacy of anti-PD-1 antibodies in cancer patients

scientific article published on 22 January 2019
Pertuzumab, trastuzumab, and standard anthracycline- and taxane-based chemotherapy for the neoadjuvant treatment of patients with HER2-positive localized breast cancer (BERENICE): a phase II, open-label, multicenter, multinational cardiac safety stu

scientific article published on 15 December 2017
Role of interferon alfa-2b in the induction and maintenance treatment of low-grade non-Hodgkin's lymphoma: results from a prospective, multicenter trial with double randomization

scientific article published on April 1, 1998
Novel anti-fatty acid synthase compounds with anti-cancer activity in HER2+ breast cancer.

scientific article published on October 2010
Effect of gamma-linolenic acid on the transcriptional activity of the Her-2/neu (erbB-2) oncogene.

scientific article published on November 2005
Selection of extreme phenotypes: the role of clinical observation in translational research.

scientific article
Natural Polyphenols and their Synthetic Analogs as Emerging Anticancer Agents.

scientific article
Consensus of the Spanish Society of Medical Oncology (SEOM) and Spanish Society of Pathology (SEAP) for HER2 testing in gastric carcinoma.

scientific article published in September 2011
Multi-level suppression of receptor-PI3K-mTORC1 by fatty acid synthase inhibitors is crucial for their efficacy against ovarian cancer cells

scientific article published on 10 January 2017
Usefulness of antibiotic-lock technique in management of oncology patients with uncomplicated bacteremia related to tunneled catheters.

scientific article published in April 2005
18F-fluoromisonidazole PET and Activity of Neoadjuvant Nintedanib in Early HER2-Negative Breast Cancer: A Window-of-Opportunity Randomized Trial.

scientific article published in September 2016
Dietary fatty acids regulate the activation status of Her-2/neu (c-erbB-2) oncogene in breast cancer cells

scientific article published on 01 November 2004
Inhibition of fatty acid synthase-dependent neoplastic lipogenesis as the mechanism of gamma-linolenic acid-induced toxicity to tumor cells: an extension to Nwankwo's hypothesis.

scientific article published in January 2005
Targeting cytoskeleton reorganisation as antimetastatic treatment.

scientific article published on October 2010
Validation of the 2001 St Gallen risk categories for node-negative breast cancer using a database from the Spanish Breast Cancer Research Group (GEICAM).

scientific article published in March 2004
Prevalence and management of anaemia in patients with non-myeloid cancer undergoing systemic therapy: a Spanish survey.

scientific article published on 19 December 2012
In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer

scientific article published in Nature Communications
Biweekly vinorelbine and gemcitabine: a phase I dose-finding study in patients with advanced solid tumors.

scientific article published on May 2003
Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology

scientific article published on 22 December 2017
Obesity, fatty acid synthase, and cancer: serendipity or forgotten causal linkage?

scientific article published on 09 December 2004
Initially metastatic breast carcinoma has a distinct disease pattern but an equivalent outcome compared with recurrent metastatic breast carcinoma

scientific article published in May 2004
Usefulness of the PERFORM questionnaire to measure fatigue in cancer patients with anemia: a prospective, observational study

scientific article published on June 22, 2013
A Fatty Acid Synthase Inhibitor Shows New Anticancer Mechanisms

scientific article
Phase I/II study of gefitinib and capecitabine in patients with colorectal cancer.

scientific article published in January 2008
Cytokeratin 5/6 fingerprinting in HER2-positive tumors identifies a poor prognosis and trastuzumab-resistant Basal-HER2 subtype of breast cancer

scientific article published on March 30, 2015
3D Assessment of Lymph Nodes vs. RECIST 1.1.

scientific article published on 7 January 2011

Paulina is supported by:

About Paulina

Help